Applications of Fluorescence In Situ Hybridization Technology in Malignancies-Reference-Cited by-同舟云学术

Applications of Fluorescence In Situ Hybridization Technology in Malignancies

Published:2016-12-02 Issue: Volume: Page:75-90
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Tansatit Montakarn

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-6703-2_8

Reference23 articles.

1. Heim S, Mitelman F (eds) (2015) Cancer cytogenetics: chromosomal and molecular genetic aberrations of tumor cells, 4th edn. Wiley-Blackwell, New York

2. Rowley JD (1973) A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290–293. doi: 10.1038/243290a0

3. Gozzetti A, Le Beau MM (2000) Fluorescence in situ hybridization: uses and limitations. Semin Hematol 37:320–333

4. Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937–951

5. Richkind K (2012) The role of classical cytogenetics in hematologic diagnosis. In: Davis BH, Kottke-Marchant K (eds) Laboratory hematology practice. Wiley-Blackwell, Oxford, UK

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytotoxic T lymphocyte‐associated antigen‐4 (CTLA-4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP);Blood Research;2024-03-01

2. Genomic technologies for detecting structural variations in hematologic malignancies;Blood Research;2024-02-13

3. Correct use of Kreatech DNA probes to detect MYC gene amplification in medulloblastomas by fluorescence in situ hybridization;Arkhiv patologii;2019